NCT04574089

Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository

Medical Ethics Committee of Peking University Shenzhen Hospital

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Peking University Shenzhen Hospital · Academic / Other
• Sex: Female
• Age: 18 Years – 55 Years
• Healthy volunteers: Not accepted

Summary

Aerobic vaginitis was treated by using Baofukang Suppository 7 days group or Baofukang Suppository 14 days group.To evaluate the efficacy and safety after treatment.

Detailed description

Aerobic vaginitis was treated by using Baofukang Suppository 7 days group or Baofukang Suppository 14 days group. Group 1: Baofukang Suppository (1.74g), for vaginal use, 2 capsules per night for 7 days. Group 2: Baofukang Suppository (1.74g), for vaginal use, 2 capsules per night for 14 days. The efficacy and safety will be evaluated 7\~14 days after treatment and 35\~42 days after treatment.

Conditions

• Vaginitis

Interventions

Type	Name	Description
DRUG	Experimental: Baofukang Suppository 7 days	Experimental: Baofukang Suppository 7 days
DRUG	Experimental: Baofukang Suppository 14 days	Experimental: Baofukang Suppository 14 days

Timeline

• Start date: 2020-05-01
• Primary completion: 2026-12-30
• Completion: 2026-12-30
• First posted: 2020-10-05
• Last updated: 2025-06-12

Locations

1 site across 1 country: China